| Traffic Technologies Ltd (TTI) ORDINARY FULLY PAID |
Industrials |
$3 |
Half Yearly Report and Accounts
|
27 Feb 2025 4:06PM |
$0.004 |
$0.002 |
fallen by
50%
|
|
TTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for the half year ended 31 December 2024 was A$9.9 million.
- Net loss for the period was A$6.7 million.
- Company's operations faced capital constraints impacting revenue.
- Strong demand for products due to government investment in infrastructure.
- Secured contract for LED streetlights with Sydney City Council.
- Transitioning to a SaaS model for recurring revenue.
- Restructuring operations to enhance efficiency and reduce costs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Echo IQ Limited (EIQ) ORDINARY FULLY PAID |
Information Technology |
$188 |
Appendix 4D 31 December 2024
|
27 Feb 2025 4:06PM |
$0.285 |
$0.320 |
risen by
12.28%
|
|
EIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement date is 27 February 2025
- Company is Echo IQ Limited
- Revenues from ordinary activities increased by 533.8% to $101,409
- Loss from ordinary activities after tax increased by 125.4% to $6,215,645
- Loss for the half-year also rose by 125.4% to $6,215,645
- No dividends paid, recommended, or declared during the current financial period
- Net tangible assets per ordinary security increased from 0.16 cents to 0.86 cents
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$8 |
$4.0m Non-Dilutionary Funding
|
27 Feb 2025 4:06PM |
$0.007 |
$0.005 |
fallen by
23.08%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Chimeric Therapeutics received A$4.0 million in non-dilutionary funding.
- Funding was provided by a US-based philanthropic family office.
- The funds are for the development of CHM CDH17 CAR-T therapy.
- CHM CDH17 targets CDH17, a marker associated with poor prognosis in gastrointestinal cancers.
- The therapy is in a Phase 1/2 clinical trial for advanced colorectal, gastric, and neuroendocrine cancers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Oohmedia Limited (OML) ORDINARY FULLY PAID |
Communication Services |
$792 |
Becoming a substantial holder
|
27 Feb 2025 4:02PM |
$1.570 |
$1.470 |
fallen by
6.37%
|
|
| RooLife Group Ltd (RLG) ORDINARY FULLY PAID |
Communication Services |
$9 |
Appendix 4D and Half Yearly Financial Statements
|
27 Feb 2025 3:57PM |
$0.004 |
$0.006 |
risen by
50%
|
|
RLG - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported revenue of $2,603,795 for the half-year ended 31 December 2024.
- Net loss of $949,742, slightly higher than the previous loss of $946,375.
- Focus on high-margin products to improve profitability.
- Strategic partnerships established in India for product distribution.
- Operational expenses reduced by 17% compared to the previous half-year.
- Company is enhancing its own brand portfolio including health and wellness products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metal Hawk Limited (MHK) ORDINARY FULLY PAID |
Materials |
$49 |
Change in substantial holding
|
27 Feb 2025 3:56PM |
$0.333 |
$0.400 |
risen by
20.30%
|
|
| Pantoro Gold Limited (PNR) ORDINARY FULLY PAID |
Materials |
$1,187 |
Notice under section 708A(5)(e) of the Corporations Act 2001
|
27 Feb 2025 3:47PM |
$0.140 |
$3.050 |
risen by
2,078.57%
|
|
| Pantoro Gold Limited (PNR) ORDINARY FULLY PAID |
Materials |
$1,187 |
Application for quotation of securities - PNR
|
27 Feb 2025 3:46PM |
$0.140 |
$3.050 |
risen by
2,078.57%
|
|
| Pantoro Gold Limited (PNR) ORDINARY FULLY PAID |
Materials |
$1,187 |
Conversion of Portion of Convertible Loan
|
27 Feb 2025 3:43PM |
$0.140 |
$3.050 |
risen by
2,078.57%
|
|
| Domain Holdings Australia Limited (DHG) ORDINARY FULLY PAID |
Communication Services |
$2,628 |
Initial Director's Interest Notice-Peter Tonagh
|
27 Feb 2025 3:37PM |
$4.360 |
$4.160 |
fallen by
4.59%
|
|
| Renu Energy Limited (RNE) ORDINARY FULLY PAID |
Utilities |
$0 |
Proposed issue of securities - RNE
|
27 Feb 2025 3:35PM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| TMK Energy Limited (TMK) ORDINARY FULLY PAID |
Energy |
$28 |
Proposed issue of securities - TMK
|
27 Feb 2025 3:32PM |
$0.004 |
$0.003 |
fallen by
14.29%
|
|
| NT Minerals Limited (NTM) ORDINARY FULLY PAID |
Materials |
$2 |
Review Highlights Fe Potential Within Woolbung BIF - Updated
|
27 Feb 2025 3:31PM |
$0.003 |
$0.002 |
fallen by
33.33%
|
|
| TMK Energy Limited (TMK) ORDINARY FULLY PAID |
Energy |
$28 |
Disclosure Document
|
27 Feb 2025 3:30PM |
$0.004 |
$0.003 |
fallen by
14.29%
|
|
| Thrive Tribe Technologies Limited (1TT) ORDINARY FULLY PAID |
Information Technology |
$4 |
Appendix 4D and Half Year Report for 31 Dec 2024
|
27 Feb 2025 3:22PM |
$0.003 |
$0.002 |
fallen by
20%
|
|
1TT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue down 61.3% to $65,779.
- Loss for the half-year increased by 11.2% to $1,241,844.
- No dividends paid during the current or previous financial period.
- Daily Food Brand Pty Ltd placed into administration.
- Company rebranded Kumu platform to MyTribe.
- Cash reserves of $666,112 as of 31 December 2024.
- Strategic review undertaken for operational improvements.
- Jade Spooner appointed as Group CEO on 21 January 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Spectur Limited (SP3) ORDINARY FULLY PAID |
Information Technology |
$3 |
H1 FY25 Financial Statements and Appendix 4D
|
27 Feb 2025 3:20PM |
$0.012 |
$0.011 |
fallen by
8.33%
|
|
SP3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Spectur achieved record revenue of $4.464 million for H1 FY25, a 7% increase from H1 FY24.
- Subscription revenue grew by 26% to $1.81 million.
- Rental revenue increased by 9% to $1.27 million.
- The company reported a net loss of $157,000, a 77% improvement from the previous year's loss.
- Cost optimization initiatives have significantly lowered ongoing expenses.
- Spectur is focusing on high-margin recurring revenue streams for stability and growth.
- The company transitioned to a new ERP system, reducing costs by 70%.
- Technological enhancements include improved backend software and new emergency response features.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy Action Limited (EAX) ORDINARY FULLY PAID |
Industrials |
$14 |
Half Year Results - Letter to Shareholders
|
27 Feb 2025 3:19PM |
$0.270 |
$0.370 |
risen by
37.04%
|
|
| Cosmo Metals Limited (CMO) ORDINARY FULLY PAID |
Materials |
$5 |
Dispatch of Entitlement Offer Prospectus
|
27 Feb 2025 3:16PM |
$0.021 |
$0.017 |
fallen by
19.05%
|
|
| Energy Action Limited (EAX) ORDINARY FULLY PAID |
Industrials |
$14 |
Half Year Results - Investor Presentation
|
27 Feb 2025 3:15PM |
$0.270 |
$0.370 |
risen by
37.04%
|
|
EAX - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 7% to $5.32 million.
- Statutory profit after tax increased by 116% to $924,259.
- EBITDA improved by 33% to $1.33 million.
- Total assets decreased by 4% to $10.046 million.
- Net assets increased by 40% to $3.258 million.
- Total liabilities reduced by 16% to $6.788 million.
- Cashflow from operating activities increased by 93% to approximately $1.41 million.
- The company's technology platform, Utilibox, is evolving to better serve customer needs.
- Focus on profitable growth and positive cashflow to decrease debt continues.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Summerset Group Holdings Limited (SNZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$2,530 |
Amendments to Master Trust Deed
|
27 Feb 2025 3:15PM |
$11.000 |
$10.500 |
fallen by
4.55%
|
|
| Energy Action Limited (EAX) ORDINARY FULLY PAID |
Industrials |
$14 |
Appendix 4D & Interim Financial Report
|
27 Feb 2025 3:13PM |
$0.270 |
$0.370 |
risen by
37.04%
|
|
EAX - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit after tax increased to $924,259, up 116% from the previous year.
- Total revenue declined by 7% to $5,324,156.
- Energy Management revenue increased by 6.6%, offsetting declines in other segments.
- Received a Research and Development Tax Incentive of $615,753.
- Cost reductions and operational efficiencies contributed to improved profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Strike Energy Limited (STX) ORDINARY FULLY PAID |
Energy |
$444 |
FY25 Half Year Results Summary
|
27 Feb 2025 3:13PM |
$0.193 |
$0.155 |
fallen by
19.48%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$30 |
Appendix 4D & Half-Year Financial Statements
|
27 Feb 2025 3:13PM |
$0.155 |
$0.145 |
fallen by
6.45%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss for half-year was $1,533,422, up 32.8% from the previous year.
- Island Pharmaceuticals is focused on repurposing small molecules as antivirals.
- ISLA-101 is being advanced in a Phase 2 clinical trial for dengue fever.
- The trial is conducted in collaboration with the US Army.
- Island began recruitment for the Phase 2a/b clinical study.
- A binding Letter of Intent was executed with BioCryst for acquiring galidesivir.
- A key patent for ISLA-101 was granted by the USPTO.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wesfarmers Limited (WES) ORDINARY FULLY PAID |
Consumer Discretionary |
$85,912 |
Update - Dividend/Distribution - WES
|
27 Feb 2025 3:12PM |
$74.410 |
$75.740 |
risen by
1.79%
|
|
| Strike Energy Limited (STX) ORDINARY FULLY PAID |
Energy |
$444 |
Half Year Financial Report
|
27 Feb 2025 3:10PM |
$0.193 |
$0.155 |
fallen by
19.48%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
